Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer

When implementing a larger batch size, various symptoms may indicate that the change is not being managed correctly. Early warning signs could include:Click to read the full article.

Recognizing early signals of issues arising from process parameter updates is crucial for preventing larger quality impacts. Here are some common symptoms observed on the production floor or in the…

Signal detection in pharmaceutical manufacturing is crucial for timely intervention. Symptoms indicating that there may be issues related to post-approval changes can include:Click to read the full article.

Identifying symptoms or signals on the manufacturing floor is critical for recognizing potential misalignments between post-approval change management and regulatory commitments. Common symptoms that may indicate a disconnect include:Click to…

Identifying symptoms of ineffective change control is essential to fostering a compliant manufacturing environment. Common indicators may include:Click to read the full article.

Effective Management of Post-Approval Changes in Pharmaceutical Quality Assurance Post-approval changes (PAC) can significantly impact product quality and regulatory compliance in pharmaceutical manufacturing. With evolving regulatory expectations, it is critical…

The first step in managing post-approval changes is recognizing the symptoms or signals that indicate the need for a change assessment. These may include:Click to read the full article.

Identifying the signals of potential issues in comparability data during post-approval changes (PAC) is paramount. Symptoms can often be systemic and may not be immediately obvious. Common signals include:Click to…

Effectively Managing Post-Approval Changes with Comparability Data In the highly regulated pharmaceutical industry, post-approval changes can be a major concern for manufacturers. These changes, if not properly managed, can lead…

In the described case, the symptoms began to surface three months after the introduction of a new excipient for tablet formulation in the production line. Several indicators alerted the quality…

During routine quality control testing, unexpected deviations in the potency of active pharmaceutical ingredients (APIs) were observed. The API batches produced with the new supplier's material displayed significant variability, which…

Identifying the early signs of unauthorized changes within your manufacturing process is crucial. Here are some typical symptoms observed on the production floor or in laboratory environments:Click to read the…